Special Issue "Recent Trends on Enzymes Inhibitors and Activators in Drug Research"
Deadline for manuscript submissions: closed (30 April 2018).
Interests: biologically active thiazole; thiazolidinone; benzohiazole; thiazolidinone derivtives with antimicrobial activity; COX/LOX, PTP1b, HIV RT enzyme inhibitors
Special Issues and Collections in MDPI journals
Special Issue in Molecules: Biologically Active Heterocyclic Compounds
Special Issue in International Journal of Molecular Sciences: Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis
Special Issue in Molecules: Recent Trends on Enzymes Inhibitors and Activators in Drug Research 3.0
It is known that enzymes are involved in many pathological conditions, such as inflammation, diabetes, microbial infections, HIV, and neoplastic diseases among others. Enzyme inhibition is universally accepted as a strategy to treat the above mentioned conditions or to alternate the mechanism involved. Thus, the aim of the current Special Issue is to collect and present recent advances in the research fields connected to inhibition of different types of enzymes, such as Cyclooxygenase-1/Cyclooxygenase-2 (COX-1/COX-2.), Lipoxygenase (LOX), Protein tyrosine phosphatase 1B (PTP-1B), Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ), reverse transcriptase, integrase, gyrase, MurB, aldose reductase, carbonic anhydrise, etc.Dr. Athina Geronikaki
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Reverse transcriptase
- aldose reductase
- carbonic anhydrise